DECTIN-1 (CLEC7A) SINGLE NUCLEOTIDE POLYMORPHISM AS A BIOMARKER FOR PREDICTING ANTIBODY RESPONSE WHEN USING β-GLUCAN AS A VACCINE ADJUVANT

摘要

The present disclosure relates generally to methods for determining whether a patient will show an enhanced immunogenic response to vaccines when using β-glucan as a vaccine adjuvant. Kits for use in practicing the methods are also provided.